Health
BioNTech/Pfizer vaccine is less potent against South African variant – Financial Times
Covid-19 jab still works but produces only a third of the antibodies it did for original virus, study finds
The BioNTech/Pfizer Covid-19 vaccine appears to be significantly less effective against the virus variant that emerged in South Africa, according to a study published on Wednesday.
The vaccine still works against the strain known as 501Y.V2, but the shot produced only a third of the antibodies that it did for the original virus in a lab study using an engineered virus.
The partners said there was “no clinical evidence” that people vaccinated with their Covid-19 shot lacked protection against the…
-
Business18 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News18 hours agoYoung voices shape Sunshine Coast’s future
-
Noosa News15 hours agoSudden death investigation, Maroochydore – Sunshine Coast
-
General22 hours agoUS stocks sink further as Donald Trump urges Americans to be ‘courageous and patient’